Toxicity Related to Radiotherapy Dose and Targeting Strategy: A Pooled Analysis of Cooperative Group Trials of Combined Modality Therapy for Locally Advanced Non–Small Cell Lung Cancer-Reference-Cited by-同舟云学术

Toxicity Related to Radiotherapy Dose and Targeting Strategy: A Pooled Analysis of Cooperative Group Trials of Combined Modality Therapy for Locally Advanced Non–Small Cell Lung Cancer

Published:2019-02 Issue:2 Volume:14 Page:298-303
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Schild Steven E.,Fan Wen,Stinchcombe Thomas E.,Vokes Everett E.,Ramalingam Suresh S.,Bradley Jeffrey D.,Kelly Karen,Pang Herbert H.,Wang Xiaofei

Funder

National Cancer Institute

Health and Medical Research Fund

National Institutes of Health

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference14 articles.

1. Exploring radiotherapy targeting strategy and dose: a pooled analysis of cooperative group trials of combined modality therapy for stage III NSCLC;Schild;J Thorac Oncol,2018

2. A randomized study of involved-field irradiation versus elective nodal irradiation in combination with concurrent chemotherapy for inoperable stage III nonsmall cell lung cancer;Yuan;Am J Clinic Oncol,2007

3. Improved local control without elective nodal radiotherapy in patients with unresectable NSCLC treated by 3D-CRT;Yang;Front Med China,2007

4. Involved-field radiotherapy versus elective nodal irradiation in combination with concurrent chemotherapy for locally advanced non-small cell lung cancer: a prospective randomized study;Chen;Biomed Res Int,2013

5. Elective nodal irradiation (ENI) vs. involved field radiotherapy (IFRT) for locally advanced non-small cell lung cancer (NSCLC): a comparative analysis of toxicities and clinical outcomes;Fernandes;Radiother Oncol,2010

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of mediastinal tumor burden and lymphatic spread in locally advanced non-small-cell lung cancer: A secondary analysis of the multicenter randomized PET-Plan trial;Radiotherapy and Oncology;2024-11

2. Nano-Assisted Radiotherapy Strategies: New Opportunities for Treatment of Non-Small Cell Lung Cancer;Research;2024-01

3. Dosimetric benefits of adaptive radiation therapy for patients with stage III non-small cell lung cancer;Radiation Oncology;2023-02-22

4. PET/CT-based adaptive radiotherapy of locally advanced non-small cell lung cancer in multicenter yDEGRO ARO 2017-01 cohort study;Radiation Oncology;2022-02-09

5. Optimal Radiation Dose for Stage III Lung Cancer—Should “Definitive” Radiation Doses Be Used in the Preoperative Setting?;JTO Clinical and Research Reports;2021-08